Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2
- Mark Dittmar
- , Jae Seung Lee
- , Kanupriya Whig
- , Elisha Segrist
- , Minghua Li
- , Brinda Kamalia
- , Lauren Castellana
- , Kasirajan Ayyanathan
- , Fabian L. Cardenas-Diaz
- , Edward E. Morrisey
- , Rachel Truitt
- , Wenli Yang
- , Kellie Jurado
- , Kirandeep Samby
- , Holly Ramage
- , David C. Schultz
- , Sara Cherry
Research output: Contribution to journal › Article › peer-review
166
Link opens in a new tab
Scopus
citations